Nexalin Technology, Inc. (NXL)
Data as of , from SEC Form 4 filings.
See up to 3 months of NXL. The 7-day demo opens the 1M and 3M ranges and puts NXL on your watchlist.
Start 7-day demoLatest NXL insider trades
About Nexalin Technology, Inc. (NXL)
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
- HOUSTON, TX
- 8
- 2022
- Nasdaq
NXL Form 4 activity by transaction type, last 90 days
No Form 4 activity for NXL in the last 90 days.
NXL insider transactions (Form 4)
2317 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mark White - Officer | Grant or award | Stock Option (right to buy)* | 1,000,000 | $0.00 | - | |
| Fleet Justin van - Officer | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| David Owens - Officer | Grant or award | Stock Option (right to buy)* | 1,000,000 | $0.00 | - | |
| Carolyn Hamby Shelton - Officer | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| Ben Hu - Director | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| Alan Kazden - Director | Grant or award | Stock Option (right to buy)* | 100,000 | $0.00 | - | |
| David Owens - Officer | Grant or award | Common stock | 36,459 | $0.00 | - | |
| Ben Hu - Director | Grant or award | Common stock | 36,459 | $0.00 | - | |
| Alan Kazden - Director | Grant or award | Common stock | 36,459 | $0.00 | - | |
| Leonard Osser - 10% Owner | Grant or award | Common Stock | 83,333 | $0.00 | - | |
| Carolyn Hamby Shelton - Officer | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| David Owens - Officer | Grant or award | Stock Option (right to buy) | 203,125 | $0.00 | - | |
| David Owens - Officer | Grant or award | Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Open-market sale | Common Stock Warrants | 23,150 | $0.02 | $403 | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 150,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Marilyn Elson - 10% Owner | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| David Owens - Officer | Open-market purchase | Common stock | 500 | $2.19 | $1K | |
| Ben Hu - Director | Grant or award | Common stock | 175,000 | $0.00 | - | |
 Leslie Bernhard - Director | Grant or award | Common stock | 49,838 | $0.00 | - |
NXL insider trading FAQ
What is the latest insider trade for NXL?
Nexalin Technology, Inc. (NXL) has filed no insider reports in the last 90 days. The most recent on record is dated 23 December 2025. The full record for NXL runs to 17 Form 4 filings, the earliest from 2 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NXL stock?
No insider purchases of NXL were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling NXL stock?
No insider sales of NXL were filed in the last 90 days. 1 sale is on record for this company.
Where can I see NXL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NXL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mark White view on EDGAR
- - Fleet Justin van view on EDGAR
- - David Owens view on EDGAR
- - Carolyn Hamby Shelton view on EDGAR
- - Ben Hu view on EDGAR
- - Alan Kazden view on EDGAR
- - David Owens view on EDGAR
- - Ben Hu view on EDGAR
- - Alan Kazden view on EDGAR
- - Leonard Osser view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where NXL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NXL with a 7-day demo
- NXL on your watchlist
- Every NXL Form 4 filing on record
- Up to 3 months of NXL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
